Company news
Cyclopharm Limited (ASX:CYC) news
Cyclopharm Limited news releases on 6ix. Latest, May 7, 2018: Cyclopharm Acquires Scandinavian Distribution Business
Press releases — page 3
Cyclopharm Acquires Scandinavian Distribution Business
May 6, 2018
40 Patient Milestone Achieved For Technegas USFDA Trial
March 28, 2018
CYC CEO Presentation 2017 Australian Microcap Conference
October 17, 2017
Technegas USFDA Clinical Trial - Patient Enrolment Underway
September 26, 2017
Cyclopharm : Technegas USFDA Clinical Trial - Patient Enrolment Underway
September 25, 2017
Cyclopharm acquires European distribution business
September 19, 2017
Advancing Molecular Imaging in NSW
September 18, 2017
Cyclopharm : Dividend/Distribution - CYC
August 28, 2017
Nuclear imaging trial aiming to clear up airway diagnosis
August 18, 2017
Cyclopharm : CYC Entitlement Offer Closed
July 6, 2017
CYC Entitlement Offer Booklet
June 13, 2017
Entitlement Offer
June 4, 2017
CYC - Positive Results of China Clinical Trial
May 31, 2017
Cyclopharm Amended 2016 Preliminary Financial Report
February 26, 2017
CYC 2016 PRELIMINARY HEADLINE UPDATE-RECORD RESULTS
February 6, 2017
CYC Achieves USFDA Agreement For Technegas Trial Design
November 23, 2016
Cyclopharm Business Update on Significant Milestones
October 12, 2016
Appendix 4D and Half Year Accounts
August 19, 2016
CYC Signs Agreement with the Canadian Association of Nuc Med
June 27, 2016
Trading Update & Record Technegas Order Received from China
June 21, 2016
Cyclopharm to Proceed Independently with FDA Trials
May 10, 2016
Cyclopharm Files Claim Against ANSTO
March 30, 2016
Technegas COPD Trial Update
February 11, 2016
Cyclopharm receives insurance settlement
February 10, 2016